News
Glenmark USA launches Axitinib Tablets, 1 mg and 5 mg
16-Nov-2026 | 09:07
Glenmark Pharmaceuticals Inc., USA (Glenmark), today announced the launch of Axitinib Tablets, 1 mg and 5 mg. This product is an Authorized Generic version of INLYTA?1 (axitinib) tablets.
According to IQVIA? sales data for the 12-month period ending September 2026, U.S. annual sales of INLYTA? Tablets were approximately $538.4 million